In the BioHarmony Drug Report Database

"Preview" Icon

Mecamylamine

Inversine (mecamylamine) is a small molecule pharmaceutical. Mecamylamine was first approved as Inversine on 1982-01-01. It is used to treat malignant hypertension and tourette syndrome in the USA. The pharmaceutical is active against neuronal acetylcholine receptor subunit alpha-3. In addition, it is known to target neuronal acetylcholine receptor subunit alpha-4, neuronal acetylcholine receptor subunit alpha-2, acetylcholine receptor subunit alpha, neuronal acetylcholine receptor subunit alpha-6, and neuronal acetylcholine receptor subunit alpha-7.

 

Trade Name

 

Inversine
 

Common Name

 

mecamylamine
 

ChEMBL ID

 

CHEMBL267936
 

Indication

 

malignant hypertension, tourette syndrome
 

Drug Class

 

Image (chem structure or protein)

Mecamylamine structure rendering